Skip to main content
. 2021 Mar 19;13(3):999. doi: 10.3390/nu13030999

Table 5.

Investigator Global Assessment of Safety (IGAS) after 4 weeks and 8 weeks of treatment.

Week Treatment n (%) Very Good Good Moderate Poor
Week 4 µsmin® Plus 37 (100) 36 (97.30) 1 (2.70) 0 0
Placebo 35 (100) 24 (68.57) 11 (31.43) 0 0
Week 8 µsmin® Plus 37 (100) 36 (97.30) 1 (2.70) 0 0
Placebo 35 (100) 31 (88.57) 4 (11.43) 0 0